Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.


Journal

Journal of the American Medical Informatics Association : JAMIA
ISSN: 1527-974X
Titre abrégé: J Am Med Inform Assoc
Pays: England
ID NLM: 9430800

Informations de publication

Date de publication:
13 08 2021
Historique:
received: 25 11 2020
revised: 25 03 2021
accepted: 04 05 2021
pubmed: 15 7 2021
medline: 3 11 2021
entrez: 14 7 2021
Statut: ppublish

Résumé

Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes. We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a clinical or research context. It is the first homegrown viewer cleared by New York State provisional approval in 2020 for primary diagnosis and remote sign-out during the COVID-19 (coronavirus disease 2019) pandemic. We further introduce an interconnected Honest Broker for BioInformatics Technology (HoBBIT) to systematically compile and share large-scale DP research datasets including anonymized images, redacted pathology reports, and clinical data of patients with consent. The solution has been operationally used over 3 years by 926 pathologists and researchers evaluating 288 903 digital slides. A total of 51% of these were reviewed within 1 month after scanning. Seamless integration of the viewer into 4 hospital systems clearly increases the adoption of DP. HoBBIT directly impacts the translation of knowledge in pathology into effective new health measures, including artificial intelligence-driven detection models for prostate cancer, basal cell carcinoma, and breast cancer metastases, developed and validated on thousands of cases. We highlight major challenges and lessons learned when going digital to provide orientation for other pathologists. Building interconnected solutions will not only increase adoption of DP, but also facilitate next-generation computational pathology at scale for enhanced cancer research.

Identifiants

pubmed: 34260720
pii: 6321440
doi: 10.1093/jamia/ocab085
pmc: PMC8344580
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1874-1884

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : National Institutes of Health/National Cancer Institute Cancer

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.

Auteurs

Peter J Schüffler (PJ)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Institute of Pathology, Technical University of Munich, Munich, Germany.

Luke Geneslaw (L)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

D Vijay K Yarlagadda (DVK)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Matthew G Hanna (MG)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Jennifer Samboy (J)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Evangelos Stamelos (E)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Chad Vanderbilt (C)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

John Philip (J)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Department of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Marc-Henri Jean (MH)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Lorraine Corsale (L)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Allyne Manzo (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Neeraj H G Paramasivam (NHG)

Department of Information Systems, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

John S Ziegler (JS)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Jianjiong Gao (J)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Juan C Perin (JC)

Department of Information Systems, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Young Suk Kim (YS)

School of Medicine, Stanford University, Stanford, California, USA.

Umeshkumar K Bhanot (UK)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Michael H A Roehrl (MHA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Orly Ardon (O)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Sarah Chiang (S)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Dilip D Giri (DD)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Carlie S Sigel (CS)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Lee K Tan (LK)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Melissa Murray (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Christina Virgo (C)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Christine England (C)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Yukako Yagi (Y)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

S Joseph Sirintrapun (SJ)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

David Klimstra (D)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Meera Hameed (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Victor E Reuter (VE)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Thomas J Fuchs (TJ)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH